Tocilizumab(subcutaneous):in a histidine buffered solution composed of ACTEMRA (180 mg/mL), polysorbate 80, L-histidine and L-histidine monohydrochloride, L-arginine and L-arginine hydrochloride, L-methionine, and water for injection
Ofatumumab: 10 mg/mL arginine, diluted hydrochloric acid, 0.019 mg/mL edetate 397 disodium, 0.2 m g/mL polysorbate 80, 6.8 m g/mL sodium acetate, 2.98 m g/mL sodium chloride, 398 and Water for Injection, USP
Vedolizumab: Each single-use vial contains 300 mg vedolizumab, 23 mg L-histidine, 21.4 mg L-histidine monohydrochloride, 131.7 mg L-arginine hydrochloride, 500 mg sucrose and 3 mg polysorbate 80. Reconstituted with 4.8ml Water for Injection
Rilonacept: Each vial contains 220 mg rilonacept (80 mg/ 1 mL after reconstitution), histidine, arginine, polyethylene glycol 3350, sucrose, and glycine at a pH of 6.5 ± 0.3
Etanercept(Enbrel): 1% sucrose, 100 mM sodium chloride, 25 mM L-arginine hydrochloride, 25 mM sodium phosphate;for lyo 40 mg mannitol 10 mg sucrose 1.2 mg tromethamine